Neuland Laboratories Share Price
Small Cap | Pharmaceuticals and health care | NSE: NEULANDLAB | BSE: 524558
₹11,439.15 -613.40 (-5.09 %)
Last Updated: 04 Apr 2025 03:58 PM
Overview
Open (₹) 12,026.75
High (₹) 12,026.75
Low (₹) 11,279.60
Prev. Close (₹) 12,052.55
Volume 72,132
VWAP (₹) 10,475.13
ROCE (%) 29.57
Industry P/E 44.73
TTM P/E 48.94
P/B Ratio 11.51
Market Cap (₹) Cr.14,676.30
Dividend Yield (%)0.12
EPS (₹) 233.89
ROE23.54%
Sales Growth (%) 30.84
Profit Growth (%)83.51
Day Range
12,026.7512,026.75
52 Week Range
5,557.0018,089.55
Historical Returns
Returns (6M)
0.84 %
Returns (1Y)
79.64 %
Returns (3Y)
855.13 %
Returns (5Y)
3533.78 %
Returns (6M)
0.84 %
Returns (1Y)
79.64 %
Returns (3Y)
855.13 %
Returns (5Y)
3533.78 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (83.52%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company with 83.52% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 33.54
MFI 27.86
ATR 954.39
Commodity Channel Index -101.76
ROC125 -14.46
ROC21 -22.68
Williams %R -91.70
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 10,933.11 | 11,255.23 | 11,610.46 | 10,577.88 | 10,255.76 | 9,900.53 | 9,578.41 |
Week Ago | 11,328.34 | 11,661.17 | 11,850.34 | 11,139.17 | 10,806.34 | 10,617.17 | 10,284.34 |
Month Ago | 13,696.66 | 14,163.28 | 14,826.61 | 13,033.33 | 12,566.71 | 11,903.38 | 11,436.76 |
EMA & SMA
11439.15
Current Price
Bullish Moving Averages
6
Bearish Moving Averages
14
5 Day 11087.90
9 Day 11265.62
10 Day 11363.80
12 Day 12020.23
14 Day 12317.25
20 Day 12838.89
26 Day 12993.66
50 Day 13430.14
100 Day 14087.69
200 Day 11700.94
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
SMALLCAP WORLD FUND INC | bulk | Sell | 12 Dec, 2024 | ₹15,618.16 | 4,84,434 | NSE |
BNP PARIBAS ARBITRAGE | bulk | Sell | 31 Aug, 2023 | ₹3,871.31 | 64,893 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 15 May, 2023 | ₹2,861.52 | 73,921 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 15 May, 2023 | ₹2,858.76 | 73,921 | NSE |
BNP PARIBAS ARBITRAGE | bulk | Buy | 15 May, 2023 | ₹2,898.38 | 70,897 | NSE |
NK SECURITIES RESEARCH PRIVATE LIMITED | bulk | Sell | 11 May, 2023 | ₹2,493.34 | 65,927 | NSE |
NK SECURITIES RESEARCH PRIVATE LIMITED | bulk | Buy | 11 May, 2023 | ₹2,491.99 | 65,827 | NSE |
EMPLOYEES RETIREMENT SYSTEM OF TEXAS - SELF MANAGED PORTFOLIO | bulk | Buy | 09 Feb, 2021 | ₹1,842.24 | 86,000 | NSE |
ROHINTON SOLI SCREWVALA | bulk | Sell | 03 Feb, 2021 | ₹1,480.60 | 86,170 | NSE |
RIKEEN P DALAL HUF | bulk | Buy | 18 Jan, 2021 | ₹1,310.71 | 80,000 | NSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
01 Mar, 2025 | Davuluri Ownership Trust | Acquisition | ₹ | 79,462 | NSE |
01 Mar, 2025 | Saharsh Rao Davuluri | Disposal | ₹ | 79,462 | NSE |
25 Feb, 2025 | Davuluri Ownership Trust | Acquisition | ₹ | 32,53,890 | NSE |
25 Feb, 2025 | Sucheth Rao Davuluri | Disposal | ₹ | 79,573 | NSE |
25 Feb, 2025 | Davuluri Vijaya Rao | Disposal | ₹ | 6,08,338 | NSE |
25 Feb, 2025 | Davuluri Ramamohan Rao | Disposal | ₹ | 25,65,979 | NSE |
05 Dec, 2023 | Nirupama Sundar | Disposal | ₹5,375.31 | 500 | NSE |
24 Aug, 2023 | Davuluri Ramamohan Rao | Disposal | ₹ | 33,500 | NSE |
24 Aug, 2023 | Davuluri Saharsh Rao | Acquisition | ₹ | 33,500 | NSE |
30 Sept, 2022 | Payal Gupta | Acquisition | ₹1,278.12 | 1,267 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
10 May, 2024 | Rs.14.0000 per share(140%)Final Dividend | 12 Jul, 2024 | 01 Jan, 1970 |
11 May, 2023 | Rs.10.0000 per share(100%)Final Dividend | 11 Jul, 2023 | 01 Jan, 1970 |
10 May, 2022 | Rs.5.0000 per share(50%)Final Dividend | 14 Jul, 2022 | 15 Jul, 2022 |
Announcements
Date | Source | Detail |
---|---|---|
02 Apr, 2025 | BSE India | Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 |
02 Apr, 2025 | NSE India | Neuland Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
25 Mar, 2025 | NSE India | NEULAND LABORATORIES LIMITED has informed the Exchange about Closure of Trading Window |
25 Mar, 2025 | NSE India | Neuland Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
19 Mar, 2025 | BSE India | Intimation about Schedule of Analyst / Institutional Investor Meeting on March 25, 2025 |
19 Mar, 2025 | NSE India | Neuland Laboratories Limited has informed the Exchange about Schedule of meet |
10 Mar, 2025 | NSE India | NEULAND LABORATORIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
10 Mar, 2025 | NSE India | Neuland Laboratories Limited has informed the Exchange about Credit Rating |
10 Mar, 2025 | BSE India | Announcement under Regulation 30 (LODR) - Credit Rating |
10 Mar, 2025 | NSE India | Neuland Laboratories Limited has informed the Exchange about change in Management |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 24 Jan, 2025 | 10 Feb, 2025 |
Quarterly Results | -- | 17 Oct, 2024 | 06 Nov, 2024 |
Quarterly Results | -- | 19 Jul, 2024 | 01 Aug, 2024 |
Audited Results & Final Dividend | -- | 24 Apr, 2024 | 10 May, 2024 |
Quarterly Results | -- | 30 Jan, 2024 | 08 Feb, 2024 |
Quarterly Results | -- | 12 Oct, 2023 | 07 Nov, 2023 |
Quarterly Results | -- | 12 Jul, 2023 | 03 Aug, 2023 |
Audited Results & Final Dividend | -- | 18 Apr, 2023 | 11 May, 2023 |
Quarterly Results | -- | 23 Jan, 2023 | 13 Feb, 2023 |
Quarterly Results | -- | 20 Oct, 2022 | 10 Nov, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
---|---|---|---|---|---|
Promoter Group | 32.68% | 32.8% | 36.14% | 36.22% | 36.25% |
Foreign Institutions + | 23.86% | 22.69% | 17.7% | 17.19% | 15.88% |
Domestic Institutions + | 9.09% | 6.02% | 6.54% | 6.18% | 7.15% |
Government | 0.4% | 0.4% | 0.46% | 0% | 0% |
Public | 33.97% | 38.09% | 39.16% | 40.41% | 40.72% |
Others | 0% | 0% | 0% | 0% | 0% |
About Neuland Laboratories
Neuland Laboratories is a Public Limited Listed company incorporated on 07/01/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004393 and registration number is 004393. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1558.58 Cr. and Equity Capital is Rs. 12.90 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1984
Managing Director
-- --
NSE Symbol
NEULANDLAB
Neuland Laboratories Management
Name | Designation |
---|---|
Dr. Davuluri Rama Mohan Rao | Executive Chairman |
Mr. Davuluri Sucheth Rao | Vice Chairman & CEO |
Mr. Davuluri Saharsh Rao | Vice Chairman & Mng.Director |
Dr. Christopher M Cimarusti | Non Executive Director |
Dr. Nirmala Murthy | Independent Director |
Mr. Homi Rustum Khusrokhan | Independent Director |
Mr. Prasad Raghava Menon | Independent Director |
Mr. Sugata Sircar | Independent Director |
Ms. Pallavi Joshi Bakhru | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35 ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50 ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Neuland Laboratories
What is the share price of Neuland Laboratories?
The share price of Neuland Laboratories on 04 Apr, 2025 is ₹ 11,439.15.
What is 52W high and 52W low share price of Neuland Laboratories?
The highest and lowest 52W share prices of Neuland Laboratories are ₹ 18089.550 and ₹ 5557.000
What is the market cap of Neuland Laboratories?
The market capitalization of Neuland Laboratories as of 04 Apr, 2025 is ₹ 14,676.30 Crores
What is the P/E ratio of Neuland Laboratories?
The current P/E ratio of Neuland Laboratories as of 04 Apr, 2025 is 44.73
What is the PB ratio of Neuland Laboratories?
The PB ratio of Neuland Laboratories as of 04 Apr, 2025 is 11.51
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)